Orbus Therapeutics' Series B Round

Orbus Therapeutics raised a round of funding on August 15, 2017.

Orbus Therapeutics is a private, clinical-stage biopharmaceutical company is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. The Company…

Articles about Orbus Therapeutics' Series B Round: